IDH 1 /2 status and low grade gliomas (LGG): Correlation with outcome upfront Pignatti criteria and molecular profile in a retrospective analysis of a single-centre cohort from Spain.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2046-2046
Author(s):  
Olatz Etxaniz ◽  
Cristina Carrato ◽  
Itziar de Aguirre ◽  
Cristina Queralt ◽  
Ana Munoz ◽  
...  
2013 ◽  
Vol 115 (12) ◽  
pp. 2508-2513 ◽  
Author(s):  
Erhan Turkoglu ◽  
Bora Gurer ◽  
Ahmet M. Sanli ◽  
Habibullah Dolgun ◽  
Levent Gurses ◽  
...  

2008 ◽  
Vol 90 (3) ◽  
pp. 341-350 ◽  
Author(s):  
Nader Pouratian ◽  
Melike Mut ◽  
Jay Jagannathan ◽  
M. Beatriz Lopes ◽  
Mark E. Shaffrey ◽  
...  

2016 ◽  
Vol 18 (suppl 3) ◽  
pp. iii89.3-iii89
Author(s):  
Noelle Cullinan ◽  
John Caird ◽  
Michael Capra ◽  
Jane Pears ◽  
Cormac Owens ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 3008
Author(s):  
Giuseppe Lombardi ◽  
Valeria Barresi ◽  
Antonella Castellano ◽  
Emeline Tabouret ◽  
Francesco Pasqualetti ◽  
...  

Diffuse low-grade gliomas (LGG) represent a heterogeneous group of primary brain tumors arising from supporting glial cells and usually affecting young adults. Advances in the knowledge of molecular profile of these tumors, including mutations in the isocitrate dehydrogenase genes, or 1p/19q codeletion, and in neuroradiological techniques have contributed to the diagnosis, prognostic stratification, and follow-up of these tumors. Optimal post-operative management of LGG is still controversial, though radiation therapy and chemotherapy remain the optimal treatments after surgical resection in selected patients. In this review, we report the most important and recent research on clinical and molecular features, new neuroradiological techniques, the different therapeutic modalities, and new opportunities for personalized targeted therapy and supportive care.


2019 ◽  
Vol 145 (3) ◽  
pp. 519-529 ◽  
Author(s):  
Steven S. Carey ◽  
Zsila Sadighi ◽  
Shengjie Wu ◽  
Jason Chiang ◽  
Giles W. Robinson ◽  
...  

Neurosurgery ◽  
2019 ◽  
Author(s):  
Tamara Ius ◽  
Daniela Cesselli ◽  
Miriam Isola ◽  
Giada Pauletto ◽  
Barbara Tomasino ◽  
...  

Abstract BACKGROUND Incidentally discovered diffuse low-grade gliomas (iLGG) are poorly documented in the literature. They are diagnosed by chance during radiological examinations. OBJECTIVE To review a cohort of patients with iLGG surgically treated in our institution, analyzing clinical, molecular, and surgical aspects. METHODS Clinical, radiological, and treatment data of iLGG were retrieved and compared with those of symptomatic diffuse LGGs (sLGG). Histological and molecular review was carried out as well. The extent of resection was evaluated on preoperative and postoperative T2-weighted magnetic resonance imaging. RESULTS Thirty-four iLGG cases were identified within a monoinstitutional cohort of 332 patients operated for low-grade gliomas from 2000 to 2017. Clinically, patients with iLGG had higher preoperative karnofsky performance scale (KPS) (P = .003), smaller tumor volume (P = .0001), lower frequency of eloquent areas involvement (P = .0001), and higher rate of complete resection (P = .0001) compared to those with sLGG. No differences in the molecular profile and O6-methylguanine-DNA-methyltransferase promoter methylation were detected between iLGG and sLGG. Importantly, patients with iLGG had longer overall survival than those with sLGG (P = .0001), even when a complete surgical resection was achieved (P = .001). CONCLUSION Although the therapeutic strategy of iLGG is still a matter of debate, our data support the safety and the effectiveness of early surgical resection. The favorable prognosis of iLGG may be due to the higher practicability of extensive resection, noneloquent tumor location, and smaller tumor volume.


2014 ◽  
Vol 16 (suppl 6) ◽  
pp. vi5-vi5
Author(s):  
A. Leggate ◽  
T. Ioannou ◽  
T. Eadsforth ◽  
J. Law ◽  
G. Hall

Author(s):  
Mohamed Reda Rady ◽  
Abd Elrhman Enayet ◽  
Amal Refaat ◽  
Hala Taha ◽  
Waleed Said ◽  
...  

Neurosurgery ◽  
2011 ◽  
Vol 68 (5) ◽  
pp. 1326-1333 ◽  
Author(s):  
Anja Smits ◽  
Hugues Duffau

Abstract OBJECTIVE: The majority of adults with low-grade gliomas have seizures. Despite the frequency of seizures as initial symptoms and symptoms of later disease, seizures in relation to the natural course of low-grade gliomas have received little attention. METHODS: In this review, we provide an update of the literature on the prognostic impact of preoperative seizures and discuss the tumor- and treatment-related factors affecting seizure control at later stages of the disease. RESULTS: Seizures occur most frequently at disease presentation and predict a more favorable outcome. Initial seizures are correlated with tumor location and possibly indirectly to the molecular profile of the tumor. About 50% of all patients with seizures at presentation continue to have seizures before surgery. Maximal tumor resection, including resection of epileptic foci, is a valuable strategy for improving seizure control. In addition, radiotherapy and chemotherapy, as single therapies or in combination with surgery, have shown beneficial effects in terms of seizure reduction. Recurrent seizures after macroscopically complete tumor resection may be a marker for accelerated tumor growth. Recurrent seizures after an initial transient stabilization after radiotherapy and/or chemotherapy may be a marker for anaplastic tumor transformation. CONCLUSION: Preoperative seizures likely reflect, apart from tumor location, intrinsic tumor properties as well. Change in seizure control in individual patients is frequently associated with altered tumor behavior. Including seizures and seizure control as clinical parameters is recommended in future trials of low-grade gliomas to further establish the prognostic value of these symptoms and to identify the factors affecting seizure control.


Sign in / Sign up

Export Citation Format

Share Document